Real-world treatment patterns, costs, and outcomes in patients with AL amyloidosis: analysis of the Optum EHR and commercial claims databases.

Angela DispenzieriJeffrey ZonderJames HoffmanSandra W WongMichaela LiedtkeRafat AbonourAnita D'SouzaCharlene LeeSarah CoteRavi PotluriEric M AmmannNamPhuong TranAnnette LamSandhya Nair

Published in: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2022)

AL amyloidosis is associated with substantial costs and suboptimal outcomes, highlighting the need for new therapeutic approaches to prevent organ deterioration, and reduce disease burden.

Keyphrases

multiple myeloma
health insurance
type diabetes
metabolic syndrome
big data
artificial intelligence